Quick Summary
Mitomet ML 40mg Injection
Last updated on 31 Mar 2026 | 09:29 AM (IST)
₹1995
MRP: ₹2625
(You Save ₹630)
1 VIAL(s)
24% OFF
₹1995
MRP: ₹2,625.00
Inclusive of all taxes
24% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Mito 40mg Injection
NEON LABORATORI...
₹ 2263.00/injection
14% costlier
Mitomycin 40mg Injection
ZYDUS CADILA
₹ 2457.00/injection
24% costlier


Introduction
Mitomet ML 40mg Injection is an antimetabolite drug belonging to the class of alkaloids cytotoxic agents containing the active ingredient Mitomycin. Mitomet ML 40mg uses for cancer treatment of various types like breast, pancreas, lungs and stomach. This injection is used alone or in combination with other anti-cancer medicines in combination with chemotherapy.
The common side effects that are likely to occur with this medicine are nausea, vomiting, tiredness, bruising, shortness of breath, and numbness. Other serious side effects include swelling of lips, severe lung disease, and kidney problems. Inform your physician if you face any of the symptoms. It is given right away or later with anticancer medicines.
Before taking Mitomet ML 40mg Injection, please inform your doctor if you have been recently vaccinated or if you have any medical conditions, especially kidney, blood or liver diseases or breathing disorders. Mitomet ML 40mg Injection can lead to blood disorders; thus, it is necessary to have regular blood tests while undergoing treatment. Do not take this injection if you are allergic to Mitomet ML 40mg Injection. Tell your physician about all the medications you are taking recently, including herbal medicines and supplements, before taking. Mitomet ML 40mg Injection substitute is Mitomycin C Injection. Mitomet ML 40mg Injection price varies by retailer and location. You can buy Mitomet ML 40mg Injection online at various platforms, such as MrMed.
Uses
Mitomet ML 40mg Injection is used to treat
pancreatic cancer, breast cancer and stomach cancer
As an adjunct to ab externo glaucoma surgery
How Mitomet ML 40mg Injection
It is an alkylating drug that works by interfering with genetic material (DNA)synthesis and the induction of DNA damage, leading to the death of cancer cells.
Interaction of Mitomet ML 40mg Injection with other drugs
Cisplatin (Severe)
Using Mitomet with cisplatin may increase the risk of kidney and bone marrow toxicity. This combination should be used only under strict medical supervision.Doxorubicin (Severe)
Concurrent use may intensify heart and bone marrow related side effects. Close monitoring by your oncologist is essential.Bleomycin (Severe)
Combining these medicines may worsen lung toxicity. Use together only if clearly required and monitored carefully.Cyclophosphamide (Moderate)
This combination can increase the risk of low blood cell counts. Regular blood tests are advised during treatment.Vincristine (Moderate)
Using both may enhance neurological side effects such as numbness or tingling. Inform your doctor if symptoms worsen.
Storage Conditions
Store Mitomet ML 40mg Injection in the original package at room temperature (25°C). Do not freeze.
Keep it out of reach from children and pets.
It is important to get the dose at the scheduled time. If you missed the schedule, contact your doctor and reschedule the dose.
How to Use Mitomet ML 40mg Injection
The medicine will be administered to you by a healthcare professional in a hospital setting. This injection will be given intravenously into a vein in your arm or hand. Do not self-administer this medicine. The dose of the injection will be decided by your doctor based on your disease condition and other factors. It is intended for topical application to the surgical site of glaucoma filtration surgery. It is not intended for intraocular administration.
During the infusion, the patient will be closely monitored for any adverse reactions, such as allergic reactions or changes in blood pressure or heart rate. Do not self-administer this medicine.
Safety Advice for Mitomet 40mg Injection
Breast Feeding
It is not known if Mitomet ML 40mg Injection passes into your breast milk or if it will affect your baby or your breast milk. Please consult your doctor before breastfeeding.
Alcohol
It is unknown whether consuming alcohol interacts with Mitomet ML 40mg Injection. Please consult your doctor for more advice.
Liver
It is unknown whether Mitomet ML 40mg Injection can be administered to patients with liver disorders. Inform your physician if you have any liver problems before starting treatment with Mitomet ML 40mg Injection.
Lungs
It is not known whether Mitomet ML 40mg Injection can be administered to patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Driving
It is unsafe to drive vehicles or operate heavy machinery after taking Mitomet ML 40mg Injection because Mitomet ML 40mg Injection contains a small amount of alcohol, which may cause dizziness and impair your concentration.
Pregnancy
It is unknown whether Mitomet ML 40mg Injection can be administered during pregnancy. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
Side Effects of Mitomet ML 40mg Injection
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Severe side effects of Mitomet ML 40mg Injection are:
Severe allergic reactions (faintness, skin rash, swelling of lips, face and airway with difficulty in breathing, loss of consciousness)
Severe lung disease
Kidney problems
Common side effects of Mitomet ML 40mg Injection are:
Nausea, vomiting
Low blood cell count
Cough, shortness of breath
Inflammation
Bruising, bleeding
Numbness, swelling and painful redness on palms and soles
Expert tips
Mitomet ML 40mg Injection can harm a developing fetus, so it should not be used during pregnancy, and effective contraception must be followed.
This injection may cause fatigue, so patients should be encouraged to get enough rest and focus on self-care during treatment.
Advise patients to avoid contact with sick individuals, maintain good hand hygiene, and take precautions to reduce infection risk.
In stomach cancer, Mitomet ML 40mg Injection may be combined with chemotherapy drugs like fluorouracil (5 FU) and cisplatin, especially in advanced or metastatic cases.
Since the medicine can weaken the immune system, patients should avoid infection exposure and include immune boosting foods like broccoli, ginger, and spinach in their diet.
FAQs about Mitomet 40mg Injection
Q1.
What is Mitomet ML 40mg Injection used for?
Mitomet ML 40mg Injection is used to treat various types of cancer, including pancreas, breast, and stomach cancers.
Q2.
What precautions should I take while receiving Mitomet ML 40mg Injection?
It is important to practice good hand hygiene, avoid contact with people who are sick, and take other steps to reduce your risk of infection while receiving Mitomet ML 40mg Injection.
Q3.
Can Mitomet ML 40mg Injection be given during pregnancy?
No, Mitomet ML 40mg Injection can cause harm to a developing fetus and should not be given during pregnancy.
Q4.
What are the common side effects of Mitomet ML 40mg Injection?
The most common side effects of Mitomet ML 40mg Injection include nausea, vomiting, diarrhoea, fatigue, hair loss, mouth sores, and increased risk of infection.
Q5.
How is Mitomet ML 40mg Injection administered?
Mitomet ML 40mg Injection can be administered intravenously, intravesically, or topically, depending on the type of cancer being treated.
Fact Box of Mitomet ML 40mg Injection
Molecule name: Mitomycin | Therapeutic class: Anti-metabolite |
Pharmacological class: Alkaloids cytotoxic agents | Indications:
|
References
- Accord Healthcare Limited, Electronic Medicines Compendium (emc), [Revised on Feb 2019] [ Accessed on 30th Nov 2021], https://www.medicines.org.uk/emc/files/pil.1956.pdf
- Mobius Therapeutics, US Food and Drug Administration, [Revised on Jan 2012] [ Accessed on 30th Nov 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022572s000lbl.pdf
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 865.
- Hadeer Sinawe, Damian Casadesus; Mitomycin; NCBI Bookshelf; Updated on 29/07/2021; Accessed on 01/12/2021; https://www.ncbi.nlm.nih.gov/books/NBK562249/
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Dr. Deva Prasath S.
Pharm D

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:29 AM (IST)

Want to know more?
Read Our Editorial Policy







